Literature DB >> 28543993

Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical Application.

Afsane Bahrami1,2, Marjan Joodi3,4, Mehrdad Moetamani-Ahmadi1, Mina Maftouh5, Seyed Mahdi Hassanian5, Gordon A Ferns6, Amir Avan5.   

Abstract

Hirschsprung's disease (HSCR) is a congenital disorder, defined by partial or complete loss of the neuronal ganglion cells in the intestinal tract, which is caused by the failure of neural crest cells to migrate completely during intestinal development during fetal life. HSCR has a multifactorial etiology, and genetic factors play a key role in its pathogenesis; these include mutations within several gene loci. These have been identified by screening candidate genes, or by conducting genome wide association (GWAS) studies. However, only a small portion of them have been proposed as major genetic risk factors for the HSCR. In this review, we focus on those genes that have been identified as either low penetrant or high penetrant variants that determine the risk of Hirschsprung's disease. J. Cell. Biochem. 119: 28-33, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GENETIC SUSCEPTIBILITY; HIRSCHSPRUNG DISEASE; VARIATIONS

Mesh:

Year:  2017        PMID: 28543993     DOI: 10.1002/jcb.26149

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

Review 1.  Disorders of the enteric nervous system - a holistic view.

Authors:  Beate Niesler; Stefanie Kuerten; I Ekin Demir; Karl-Herbert Schäfer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-01-29       Impact factor: 46.802

2.  Clinical significance and biological effect of ZFAS1 in Hirschsprung's disease and preliminary exploration of its underlying mechanisms using integrated bioinformatics analysis.

Authors:  Yujiao Wang; Peng Cai; Jian Wang
Journal:  Ir J Med Sci       Date:  2022-01-06       Impact factor: 1.568

Review 3.  [Syndromic Hirschsprung′s disease and its mode of inheritance].

Authors:  Jing-Ru Zhang; Zhi-Bo Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

4.  NOX5 is expressed aberrantly but not a critical pathogenetic gene in Hirschsprung disease.

Authors:  Jing Wang; Jun Xiao; Xinyao Meng; Xufeng Chu; Di Di Zhuansun; Bo Xiong; Jiexiong Feng
Journal:  BMC Pediatr       Date:  2021-03-30       Impact factor: 2.125

5.  LncRNA DRAIC regulates cell proliferation and migration by affecting the miR-34a-5p/ITGA6 signal axis in Hirschsprung's disease.

Authors:  Chuancheng Sun; Bing Xu; Liang Wang; Yilin Su
Journal:  Ups J Med Sci       Date:  2021-08-20       Impact factor: 2.384

6.  Association of VAMP5 and MCC genetic polymorphisms with increased risk of Hirschsprung disease susceptibility in Southern Chinese children.

Authors:  Jinglu Zhao; Xiaoli Xie; Yuxiao Yao; Qiuming He; Ruizhong Zhang; Huimin Xia; Yan Zhang
Journal:  Aging (Albany NY)       Date:  2018-04-25       Impact factor: 5.682

7.  Association between DSCAM polymorphisms and non-syndromic Hirschsprung disease in Chinese population.

Authors:  Yong Wang; Qiuming He; Ruizhong Zhang; Wei Zhong; Deli Zhu; Yan Zhang; Huimin Xia
Journal:  BMC Med Genet       Date:  2018-07-13       Impact factor: 2.103

8.  Sequence characterization of RET in 117 Chinese Hirschsprung disease families identifies a large burden of de novo and parental mosaic mutations.

Authors:  Qian Jiang; Yang Wang; Qi Li; Zhen Zhang; Ping Xiao; Hui Wang; Na Liu; Jian Wu; Feng Zhang; Aravinda Chakravarti; Wei Cai; Long Li
Journal:  Orphanet J Rare Dis       Date:  2019-10-30       Impact factor: 4.123

9.  A complementary study approach unravels novel players in the pathoetiology of Hirschsprung disease.

Authors:  Tanja Mederer; Stefanie Schmitteckert; Julia Volz; Cristina Martínez; Ralph Röth; Thomas Thumberger; Volker Eckstein; Jutta Scheuerer; Cornelia Thöni; Felix Lasitschka; Leonie Carstensen; Patrick Günther; Stefan Holland-Cunz; Robert Hofstra; Erwin Brosens; Jill A Rosenfeld; Christian P Schaaf; Duco Schriemer; Isabella Ceccherini; Marta Rusmini; Joseph Tilghman; Berta Luzón-Toro; Ana Torroglosa; Salud Borrego; Clara Sze-Man Tang; Mercè Garcia-Barceló; Paul Tam; Nagarajan Paramasivam; Melanie Bewerunge-Hudler; Carolina De La Torre; Norbert Gretz; Gudrun A Rappold; Philipp Romero; Beate Niesler
Journal:  PLoS Genet       Date:  2020-11-05       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.